Lack of effect of pertussis toxin on TNF-α-induced formation of reactive oxygen intermediates by human neutrophilsMEURER, R; MACINTYRE, D. E.Biochemical and biophysical research communications (Print). 1989, Vol 159, Num 2, pp 763-769, issn 0006-291XArticle

Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase CMACINTYRE, D. E; BUSHFIELD, M; SHAW, A. M et al.FEBS letters. 1985, Vol 188, Num 2, pp 383-388, issn 0014-5793Article

Platelet inositol lipid metabolism and calcium fluxDRUMMOND, A. H; MACINTYRE, D. E.Research monographs in cell and tissue physiology. 1987, Vol 13, pp 373-431, issn 0378-6129Article

Possible mechanisms of the potentiation of blood-platelet activation by adrenalineBUSHFIELD, M; MCNICOL, A; MACINTYRE, D. E et al.Biochemical journal (London. 1906). 1987, Vol 241, Num 3, pp 671-676, issn 0006-2936Article

Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D₂: differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMPBUSHFIELD, M; MCNICOL, A; MACINTYRE, D. E et al.Biochemical journal (London. 1906). 1985, Vol 232, Num 1, pp 267-271, issn 0006-2936Article

Phospholipid-induced human platelet activation: effects of calcium channel blockers and calcium chelatorsMACINTYRE, D. E; SHAW, A. M.Thrombosis research. 1983, Vol 31, Num 6, pp 833-844, issn 0049-3848Article

3-Pyridyloxypropanolamine agonists of the β₃ adrenergic receptor with improved pharmacokinetic propertiesWEBER, A. E; OK, H. O; KAO, J et al.Bioorganic & medicinal chemistry letters (Print). 1998, Vol 8, Num 16, pp 2111-2116, issn 0960-894XArticle

Melanocortin mediated inhibition of feeding behavior in ratsMURPHY, B; NUNES, C. N; RONAN, J. J et al.Neuropeptides (Edinburgh). 1998, Vol 32, Num 6, pp 491-497, issn 0143-4179Article

The role of CD18 in IL-8 induced dermal and synovial inflammationFORREST, M. J; EIERMANN, G. J; MEURER, R et al.British journal of pharmacology. 1992, Vol 106, Num 2, pp 287-294, issn 0007-1188Article

5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitorsEVANS, J. F; LEVEILLE, C; LUELL, S et al.Molecular pharmacology. 1991, Vol 40, Num 1, pp 22-27, issn 0026-895XArticle

The novel NK₁ receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferretsTATTERSALL, F. D; RYCROFT, W; SADOWSKI, S et al.Neuropharmacology. 2000, Vol 39, Num 4, pp 652-663, issn 0028-3908Article

L-770,644 : A potent and selective human β₃ adrenergic receptor agonist with improved oral bioavailabilitySHIH, T. L; CANDELORE, M. R; MILLER, R. R et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 9, pp 1251-1254, issn 0960-894XArticle

An NK₁ receptor antagonist affects the circadian regulation of locomotor activity in golden hamstersCHALLET, E; NAYLOR, E; METZGER, J. M et al.Brain research. 1998, Vol 800, Num 1, pp 32-39, issn 0006-8993Article

Stimulation of human polymorphonuclear leukocytes by leukotriene B₄ and platelet-activating factor : an ultrastructural and pharmacological studyROSSI, A. G; MACINTYRE, D. E; JONES, C. J. P et al.Journal of leukocyte biology. 1993, Vol 53, Num 2, pp 117-125, issn 0741-5400Article

Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responsesMENETSKI, J; MISTRY, S; LU, M et al.Neuroscience. 2007, Vol 149, Num 3, pp 706-714, issn 0306-4522, 9 p.Article

Human β₃ adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesNAYLOR, E. M; PARMEE, E. R; FORREST, M. J et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 5, pp 755-758, issn 0960-894XArticle

3-Benzyloxy-2-phenylpiperidine NK₁ antagonists : The influence of alpha methyl substitutionSWAIN, C. J; WILLIAMS, B. J; MACINTYRE, D. E et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 23, pp 2959-2962, issn 0960-894XArticle

Synthesis and biological evaluation of NK₁ antagonists derived from L-tryptophanMACLEOD, A. M; CASCIERI, M. A; TATTERSALL, F. D et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 6, pp 934-941, issn 0022-2623Article

Identification of a series of 3-(benzyloxy)-1-azabicyclo[2.2.2]octane human NK₁, antagonistsSWAIN, C. J; SEWARD, E. M; TEALL, M et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 24, pp 4793-4805, issn 0022-2623Article

MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factorHWANG, S.-B; LAM, M.-H; SZALKOWSKI, D. M et al.Journal of lipid mediators. 1993, Vol 7, Num 2, pp 115-134, issn 0921-8319Article

Proceedings/Mechanisms of stimulus-response coupling in platelets, symposium, University of London, 26th-27th September 1984WESTWICK, J; SCULLY, M. F; MACINTYRE, D. E et al.Advances in experimental medicine and biology. 1985, Vol 192, issn 0065-2598, XI-444 pConference Proceedings

Human β₃ adrenergic receptor agonists containing cyclic ureidobenzenesulfonamidesPARMEE, E. R; NAYLOR, E. M; HOM, G. J et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 5, pp 749-754, issn 0960-894XArticle

3-pyridylethanolamines : Potent and selective human β₃ adrenergic receptor agonistsNAYLOR, E. M; COLANDREA, V. J; STRADER, C. D et al.Bioorganic & medicinal chemistry letters (Print). 1998, Vol 8, Num 21, pp 3087-3092, issn 0960-894XArticle

Structural optimization affording 2-(R)-1-((R)-3,5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4-(3- oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonistHALE, J. J; MILLS, S. G; EIERMANN, G et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 23, pp 4607-4614, issn 0022-2623Article

2(S)-(3,5-bis(trifluoromethyl)benzyl)-oxy-3(S)-phenyl-4-((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine (1) : A potent, orally active, morpholine-based human neurokinin-1 receptor antagonistHALE, J. J; MILLS, S. G; METZGER, J. M et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 9, pp 1760-1762, issn 0022-2623Article